Kids' med plans include text messageOnline AthensThat's a million-dollar question — and one that frustrates moms and dads, docs and researchers: Almost half of kids (and adults, too) who need regular dosing of inhaled corticosteroids don'…
Organ recipient says drug costs 'ridiculous'
Harvey Station resident Heather MacInnis received a double-lung transplant in February but the 25-year-old says the biggest hurdle is trying to get her medication costs covered.
Meta-Analysis Compares Drug-Eluting and Bare-Metal Stents for Primary Angioplasty – Forbes
Meta-Analysis Compares Drug-Eluting and Bare-Metal Stents for Primary AngioplastyForbes… members of the Drug-Eluting Stent in Primary Angioplasty (DESERT) Cooperation pooled patient data from more than 11 clinical trials in which more than 8600 patie…
What Is the Clinical Importance of Subclinical Hyperthyroidism? – Archives of Internal Medicine
What Is the Clinical Importance of Subclinical Hyperthyroidism?Archives of Internal MedicineFactors that may alter TSH value and thyroid function test results include medications such as corticosteroids and dopamine and clinical conditions to include h…
Organ donation not un-Islamic, says Naek – The Nation, Pakistan
Organ donation not un-Islamic, says NaekThe Nation, PakistanKARACHI – Federal Law Minister Farooq H Naek has said organ donation and transplantation is not un-Islamic, as our religion attaches great value to saving human life. Speaking as a chief guest…
BioTimes Subsidiary Cell Cure Neurosciences, Ltd. Provides Update on OpRegen® Product Development
BioTime, Inc. (NYSE Amex: BTX) announced today that Charles S. Irving, Ph.D., the CEO of BioTimes subsidiary Cell Cure Neurosciences, Ltd. will provide …
BioTime's Subsidiary Cell Cure Neurosciences, Ltd. Provides Update on OpRegen … – MarketWatch (press release)
BioTime's Subsidiary Cell Cure Neurosciences, Ltd. Provides Update on OpRegen …MarketWatch (press release)The use animal products to culture cells often results in the designation of the therapy as a "xenotransplantation" product, even …
BioTime’s Subsidiary Cell Cure Neurosciences, Ltd. Provides Update on OpRegen® Product Development
BioTime, Inc. announced today that Charles S. Irving, Ph.D., the CEO of BioTime’s subsidiary Cell Cure Neurosciences, Ltd. will provide an update on the development of OpRegen® at an investor meeting in New York City.
Finding stem cell donor match warden's 'only hope' for fighting cancer – Bangor Daily News
Finding stem cell donor match warden's 'only hope' for fighting cancerBangor Daily News“Basically, it's my only hope,” Sanborn said of the stem-cell transplant he has been left to hope for. “If it works, I'll be cured. And if …
Former VP Cheney: Heart Transplant 'Unbelievable' Gift
Former Vice President Dick Cheney expressed his gratitude today to the family that donated the organ he received during a heart transplant at the end of March. “It’s the kind of gift that’s unbelievable,” Cheney said, speaking at length to stud…